Prelude Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $236K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $207K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $148K | Buy |
|
|||||
|
2020
Q2 | $8K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $44K | Buy |
|
|||||
|
2018
Q4 | $17K | Sell |
|
|||||
|
2018
Q3 | $1.48M | Sell |
|
|||||
|
2018
Q2 | $1.49M | Sell |
|
|||||
|
2018
Q1 | $1.55M | Buy |
|
|||||
|
2017
Q4 | $1.14M | Sell |
|
|||||
|
2017
Q3 | $2.65M | Buy |
|
|||||
|
2017
Q2 | $1.56M | Buy |
|
|||||
|
2017
Q1 | $889K | Buy |
|
|||||
|
2016
Q4 | $651K | Sell |
|
|||||
|
2016
Q3 | $1.44M | Buy |
|
|||||
|
2016
Q2 | $298K | Sell |
|
|||||
|
2016
Q1 | $279K | Buy |
|
|||||
|
2015
Q4 | $379K | Sell |
|
|||||
|
2015
Q3 | $322K | Buy |
|
|||||
|
2015
Q2 | $62K | Buy |
|
|||||
|
2015
Q1 | $20K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $39K | Sell |
|
|||||
|
2014
Q2 | $111K | Sell |
|
|||||
|
2014
Q1 | $341K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $17K | Buy |
|